Dr Sandeep Rajan, technical specialist in the Cellular Platforms team at the Wellcome Sanger Institute in Hinxton, near Cambridge, has answered five questions about CRISPR/Cas.
Dr Rajan explains how the genome-editing approach works and how it could be used in research and healthcare. He discusses the origins of CRISPR/Cas as a bacterial defence system, its development as a genome-editing method and efforts to make genome editing more scalable and effective.
Read more in the Wellcome Sanger Institute blog.